SEATTLE, Oct. 8, 2012 (GLOBE NEWSWIRE) -- Attorney Advertising Material. Keller Rohrback announces that it is investigating the recent outbreak of fungal meningitis that is linked to contaminated steroid medications. The steroid medication, methylprednisolone acetate, that is linked to the contamination is manufactured by New England Compounding Center. The epidural steroid injections are administered to individuals suffering from back pain via an injection in and around the spinal cord. The Company has issued a recall of all its products "compounded and distributed" from its Framingham, Massachusetts facility.
The Centers for Disease Control and Prevention ("CDC") has confirmed that there are over 90 cases of fungal meningitis in seven states and that the seven deaths reported so far are consistent with fungal infection. The affected patients started experiencing meningitis symptoms: worsening headaches, fever, stiff neck, slurred speech, etc., one to four weeks after they received the steroid injection. Fungal Meningitis is an infection that results from a fungus that has spread through blood to the spinal cord.
If you or someone you know has been seriously harmed as a result of receiving an epidural steroid injection that was part of the New England Compounding Center recall or you would like additional information regarding this investigation, please contact attorneys Mike Woerner or Mark Samson at (800) 776-6044 or via email at info@kellerrohrback.com.
Keller Rohrback, with offices in Seattle, Phoenix, New York, and Santa Barbara, has successfully represented hundreds of clients injured by prescription drugs such as Fen-Phen, Baycol, and Vioxx. Our Complex Litigation Group is proud to offer its expertise in personal injury cases to clients nationwide. Keller Rohrback's trial lawyers have obtained judgments and settlements on behalf of clients in excess of seven billion dollars.
Attorney Advertising Material. Prior Results Do Not Guarantee A Similar Outcome.